albumin binding raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-14 and is reviewed periodically as new material appears.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强，从而延长循环半衰期，支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征，减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用，属于既定的药代动力学策略。
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
McDivitt, to White: I'm going out to PUSH-TO-TALK and see what the Flight Director has got to say. Flight Director Chris Kraft, to Grissom: The flight director says, get back in! (Kraft was not on the air-to-ground loop with the astronauts.) McDivitt: Gus, this is Jim. Got any message for us? Grissom: Gemini 4, get back in! McDivitt: Okay. ... (to White): ... They want you to come back in now.
=== Technology in government === Newsom released his first book, Citizenville: How to Take the Town Square Digital and Reinvent Government, on February 7, 2013. The book discusses the Gov 2.0 movement taking place across the nation. After its release, Newsom began to work with the Center for Information Technology Research in the Interest of Society at the University of California, Berkeley, on the California Report Card (CRC). The CRC is a mobile-optimized platform that allows state residents to "grade" their state on six timely issues. The CRC exemplifies ideas presented in Citizenville, encouraging direct public involvement in government affairs via technology. In 2015, Newsom partnered with the Institute for Advanced Technology and Public Policy at California Polytechnic State University to launch Digital Democracy, an online tool that uses facial and voice recognition to enable users to navigate California legislative proceedings.
There are major differences between Hong Kong's legal system and the rest of China's. Its judicial system is based on common law, continuing the legal tradition established during British rule. Local courts may refer to precedents set in English law and overseas jurisprudence. However, mainland criminal procedure law applies to cases investigated by the Office for Safeguarding National Security of the CPG in the HKSAR. Interpretative and amending power over the Basic Law and jurisdiction over acts of state lie with the central authority, making regional courts ultimately subordinate to the mainland's socialist civil law system. Decisions made by the Standing Committee of the National People's Congress override any territorial judicial process. Furthermore, in circumstances where the Standing Committee declares a state of emergency in Hong Kong, the State Council may enforce national law in the region. The territory's jurisdictional independence is most apparent in its immigration and taxation policies. The Immigration Department issues passports for Chinese nationals which differ from those of the mainland or Macau, and the region maintains a regulated border with the rest of the country. All travellers between Hong Kong, mainland China, and Macau must pass through border controls, regardless of nationality. Mainland Chinese residents do not have right of abode in Hong Kong and are subject to immigration controls. Public finances are handled separately from the national government, and taxes levied in Hong Kong do not fund the central authority.
== Folk medicine == Cannabis tea was used for centuries in folk medicine as it was thought to be a treatment for rheumatism, cystitis, and various urinary diseases. In an article in Nature, it is projected that cannabis has been used medicinally for nearly 12,000 years. The oldest confirmed reference to medicinal cannabis is ~2700 BC, in Ancient China. There is ~190AD evidence that a Chinese physician, Hua T'o, used an emulsion of tea and wine to anesthetize a patient for surgery. According to a short communication published in the Journal of Ethnopharmacology, based on the research of Zias et al. regarding cannabis use in ancient childbirth, cannabis is said to have been used to assist women during childbirth. The communication is regarding an anthropological find of a birthing mother, dated to the 4th century AD., "We assume that the ashes found in the tomb were cannabis, burned in a vessel and administered to the young girl as an inhalant to facilitate the birth process." Cannabis tea has been traditionally used by Jamaican women as a remedy for morning sickness associated with pregnancy. There is no evidence that cannabis is an abortive medicine."
Anemia Elevated creatine kinase (CPK) Elevated creatinine Elevated transaminases Hypercapnia Hypercholesterolemia (elevated LDL) Hyperlipidemia Hypoglycemia Hyponatremia Hypoxia Leukopenia Respiratory acidosis
Sources: en.wikipedia.org
The fund bought the remaining 80% of Truist, together with Stone Point Capital, Clayton, Dubilier & Rice and other investors, for $15.5 billion in 2024. In May 2023, Mubadala agreed to buy a majority stake in a New York–based Fortress Investment Group from the SoftBank Group. The $3 billion takeover was intended to be closed in the first quarter of 2024. However, the deal that would give Mubadala 70% stakes in Fortress was being scrutinized by the U.S. national security officers. The deal, which raised concerns for the US over the UAE's ties with China, was being closely reviewed by the Committee on Foreign Investment in the US (Cfius). In May 2024, the regulatory body approved of the sale. A year later in April 2025, Mubadala and Fortress Investment started a $1 billion investment partnership. Mubadala increased its partnership with Aldar Properties in September 2024 with four joint ventures amounting to more than $8.2 billion across Abu Dhabi. In September 2024, Turkish Competition Authority confirmed that Mubadala applied to acquire Getir in entirety. In June 2024, Getir founders, Nazim Salur and Serkan Borancili, opposed Mubadala's restructuring plan that would separate profitable local grocery delivery operations with noncore businesses. Under the proposed plan, Mubadala was to acquire grocery delivery operations in exchange for $250 million investment. However, in January 2025, Salur alleged Mubadala of an “illegal coup” and vowed to take legal action against the Emirati firm.
== Medical uses == Cilostazol is approved for the treatment of intermittent claudication in the United States and United Kingdom. If no improvement is seen after 3 months, stopping the medication is reasonable. Cilostazol is also used for secondary stroke prevention, though to date no regulatory body has approved it specifically for that indication.
=== Prosecution === Filomena Teixeira said that police did not investigate members of the family, neighbors and Dias' car, in which witnesses said they saw Mendonça go into. She also said she was sexually harassed by one of the investigators."In the Judiciary Police they were incompetent at first, the case was very badly treated. It was the worst nightmare I could have. I was alone fighting against incompetent people. They even told me that they weren't ready for these kind of things. How is that possible? (...) At the time they didn't do anything. They said [that I couldn't] go to the hills [to look for my son]. They said that they didn't like me." "[I] went everyday to the police to know if they had done something. I look in their files, everything was on paper and then there were tapes. In the beginning they had computers and they didn't know how to work with computers, because the officers there were old and didn't know how to work with computers."
=== Prevalence === Of the 350 million to 400 million individuals worldwide infected with the hepatitis B virus (HBV), one-third reside in China, with 130 million carriers and 30 million chronically infected. Since the Expanded Program on Immunization (EPI) beginning 1992, the prevalence of HBV has declined, especially among children 3 to 12 years old. During a 5-year period, 10.0% of patients with chronic hepatitis developed cirrhosis, and 20.3% of the cases with compensated cirrhosis progressed to decompensated cirrhosis. 6.5% of the people with cirrhosis and chronic hepatitis progressed to hepatocellular carcinoma (HCC). 5-year survival for compensated cirrhosis is 55%, that for decompensated cirrhosis is 14%, and that for HCC is less than 5%. Every year, 300,000 people die from HBV-related diseases in China, including 180,000 patients with HCC. However, the incidence of hepatitis B is still increasing, from 21.9 in 100,000 people in 1990 to 53.3 in 100,000 in 2003. That increase has occurred despite a vaccination program for newborn babies since the 1990s, which showed good effectiveness for reducing chronic HBV infection in children.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.